Eléments de l'association

	Olivier Rascol	92
	Confidence Intervals	9
	Olivier Rascol *Sauf* Confidence Intervals"	88
	Confidence Intervals *Sauf* Olivier Rascol"	5
	Olivier Rascol Et Confidence Intervals	4
	Olivier Rascol Ou Confidence Intervals	97
	*Corpus*	679

List of bibliographic references

Number of relevant bibliographic references: 4.

Ident.	Authors (with country if any)	Title
000217	Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]	Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000316	Joaquim Ferreira [Portugal] ; João Maia Silva [Portugal] ; Rita Freire [Portugal] ; João Pignatelli [Portugal] ; Leonor Correia Guedes [Portugal] ; Alexandra Feij [Portugal] ; Mário Miguel Rosa [Portugal] ; Miguel Coelho [Portugal] ; João Costa [Portugal] ; Ana Noronha [Portugal] ; Russell Hewett [Portugal] ; A. Marques Gomes [Portugal] ; J. L. Cirne De Castro [Portugal] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal]	Skin cancers and precancerous lesions in Parkinson's disease patients
000371	Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni]	Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa
000560	Korczyn [Israël] ; David J. Brooks [Royaume-Uni] ; Ehrout R. Brunt [Pays-Bas] ; Warner H. Poewe [Autriche] ; Olivier Rascol [France] ; Fabrizzio Stocchi [Italie]	Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: A 6‐month interim report of a 3‐year study

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024